FDA Orange Book · active-ingredient family
Fexofenadine hydrochloride
Fexofenadine hydrochloride is approved as 5 brand and 19 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:CHILDREN'S ALLEGRA ALLERGY · NDA 201373
5
Brand (NDA)
19
Generics (ANDA)
1
Listed patents
0
Exclusivity periods
Brand (NDA) products · capsule, suspension, tablet, tablet, orally disintegrating
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| CHILDREN'S ALLEGRA ALLERGYRLD×2 | CHATTEM SANOFI | NDA 201373 | — | Jan 24, 2011 | |
| CHILDREN'S ALLEGRA ALLERGYRLD×2 | CHATTEM SANOFI | NDA 021909 | — | Jan 24, 2011 | |
| ALLEGRA ALLERGYRLD×6 | CHATTEM SANOFI | NDA 020872 | — | Jan 24, 2011 | |
| ALLEGRARLD | CHATTEM SANOFI | NDA 021963 | — | Oct 16, 2006 | |
| ALLEGRA | CHATTEM SANOFI | NDA 020625 | — | Jul 25, 1996 |
Generic (ANDA) products (19)
Listed patents (1)
| Patent | Expires | In | Type |
|---|---|---|---|
| 8933097 | Aug 02, 2030 | in 4 yr 2 mo | Product |
Fexofenadine hydrochloride — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

